Abstract. Immunity responses and immunotherapy are novel areas of research for the pathological development and treatment of glioma, the most common brain cancer. Characterization of the subpopulations of infiltrated immune cells may aid in our understanding of the tumor immune response and contribute to the identification of cellular targets for selective immunotherapy. Using a rat C6 glioma model, the present study observed a significant heterogeneity of active macrophages and microglia, including cluster of differentiation 8 (CD8) + , endothelial monocyte-activating polypeptide II (EMAPII) + and ED1 + cells, mostly in the areas of compact tumor growth and inside or around the pannecrosis. Moreover, the CD8 + cells were similar to reactive ED1 + and EMAPII + microglia/macrophages in morphology and distribution, but different from the W3/13 + T cells. These observations suggest that different subtypes of macrophages and microglia are involved in glioma development and thus, may be potential targets for immunotherapeutic antitumor strategies.
IntroductionGlioma, which occurs in the central nervous system (CNS), is the most common primary malignant tumor, with an unacceptably poor prognosis despite the application of a variety of treatments, including surgery, radiotherapy and chemotherapy (1). In recent years, accumulated data have established that the immune network may be involved in regulating glioma development and growth (2). Moreover, tumor cells have been killed following direct immunization experiments using vaccines in mice, indicating its role in specific protective immunity and tumor destruction mediated by immune cells, such as microglia/macrophages (3). These immunotherapies exert a highly specific, long-term fatal effect on tumor cells by stimulating and supplementing the body's antitumor immunity (4,5), with only minimal adverse reactions (6). However, in the past decade, the main debate has focused on whether immunity exhibits an antitumor role in the CNS or functions as a tumor growth promoter (7). Additionally, the functions and mechanism of different immune cells in glioma require further investigation.Various pathological stimuli, including brain injury (8), neurodegeneration (9), infection, inflammation (10) and brain tumors (11), can activate brain macrophages/microglia. It has been observed that in CNS tumors, activated microglia/macrophages can engulf tissue debris and secrete growth-promoting factors, leading to regeneration (12). By contrast, the overactivation of microglia/macrophages will lead to tissue damage in the CNS (13). Following activation, microglia/macrophages change their morphology, upregulate the expression of certain membrane proteins and produce certain cytokines, resulting in inflammation and tissue loss (14). The contrast in roles played by activated microglia/macrophages may be due to the existence of different subpopulations of microglia/macrophages (15).Endothelial monocyte-activating polypeptide II (EMAPII) + macrophages secrete proinflammatory and antiangiogenic ...